GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Aarey Drugs & Pharmaceuticals Ltd (BOM:524412) » Definitions » Capital Expenditure

Aarey Drugs & Pharmaceuticals (BOM:524412) Capital Expenditure : ₹0.00 Mil (TTM As of Dec. 2023)


View and export this data going back to 1994. Start your Free Trial

What is Aarey Drugs & Pharmaceuticals Capital Expenditure?

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Aarey Drugs & Pharmaceuticals's cash flow for capital expenditures for the three months ended in Dec. 2023 was ₹0 Mil. Its cash flow for capital expenditures for the trailing twelve months (TTM) ended in Dec. 2023 was ₹0.00 Mil.

Aarey Drugs & Pharmaceuticals Capital Expenditure Historical Data

The historical data trend for Aarey Drugs & Pharmaceuticals's Capital Expenditure can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aarey Drugs & Pharmaceuticals Capital Expenditure Chart

Aarey Drugs & Pharmaceuticals Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Capital Expenditure
Get a 7-Day Free Trial Premium Member Only Premium Member Only -12.48 -9.19 -28.79 -22.01 -10.44

Aarey Drugs & Pharmaceuticals Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Capital Expenditure Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Aarey Drugs & Pharmaceuticals Capital Expenditure Calculation

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Capital Expenditure for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Aarey Drugs & Pharmaceuticals (BOM:524412) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Aarey Drugs & Pharmaceuticals Ltd (BOM:524412) » Definitions » Capital Expenditure
Comparable Companies
BOM:531592 BOM:524632 BOM:524506 BOM:524572 BOM:506128 BOM:524828 BOM:538964 BOM:531569 BOM:540694 BOM:539938 ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692
Traded in Other Exchanges
AAREYDRUGS:India
Address
340/348, Narshi Natha Street, 107, Sahakar Bhavan, Masjid, Mumbai, MH, IND, 400 009
Website
http://www.aareydrugs.com
Aarey Drugs & Pharmaceuticals Ltd is engaged in bulk drug manufacturing and offers products for industrial applications. The company manufactures active pharmaceutical ingredients, intermediates, and specialty chemicals. It is also involved in the trading of industrial solvents and chemicals. The products offered by the company include N-Methyl urea, Dimethyl urea, Mefenamic acid, Metformin, Doxaphylline, BMD among others. The company principally carries its business operations in India.

Aarey Drugs & Pharmaceuticals (BOM:524412) Headlines

No Headlines